Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “oxytocin” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 27
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 27 pipeline programs matching "oxytocin" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

27 results for “oxytocin” Back to intelligence hub

Search results

Page 1 of 2
  1. 1. Intranasal oxytocin spray

    United Therapeutics Europe Ltd

    Autism Spectrum Disorder

    phase 2 small molecule active

    1 trial
  2. Intranasal Oxytocin

    United Therapeutics Europe Ltd

    Autism Spectrum Disorder

    phase 2 small molecule completed

    1 trial
  3. Oxytocin

    BRIGHT MINDS BIOSCIENCES INC.

    Social Cognition

    phase 2 small molecule completed

    1 trial
  4. Oxytocin

    United Therapeutics Europe Ltd

    Alcohol Use Disorder

    phase 2 small molecule completed

    1 trial
  5. Oxytocin nasal spray

    COGNITION THERAPEUTICS INC

    Oxidative Stress

    phase 2 small molecule completed

    1 trial
  6. Oxytocin nasal spray

    COGNITION THERAPEUTICS INC

    Cold Exposure

    phase 2 small molecule completed

    1 trial
  7. Intranasal Oxytocin (IN-OXT)

    Tonix Pharmaceuticals Holding

    Vasopressin Deficiency

    phase 1 small molecule active

    1 trial
  8. Oxytocin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Oxytocin Effect on Memory Performance During Phase 1

    phase 1 small molecule completed

    1 trial
  9. Oxytocin

    United Therapeutics Europe Ltd

    Unit Cohesion

    phase 1 small molecule completed

    1 trial
  10. Oxytocin lower does (24IU)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy Adult Male

    phase 1 small molecule active

    1 trial
  11. Oxytocin lower dose (24IU)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healhty

    phase 1 small molecule active

    1 trial
  12. Oxytocin nasal spray

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy

    phase 1 small molecule completed

    1 trial
  13. Oxytocine and migraine

    Disc Medicine

    This is a study in healthy volunteers. We will study the trigeminovascular system, which is relevant in the pathophysiology of migraine.

    phase 1 other active

    1 trial
  14. oxytocin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy

    phase 1 small molecule active

    6 trials
  15. Intranasal Oxytocin (OT) 24 IU

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy Participants

    small molecule active

    1 trial
  16. Oral Oxytocin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy

    small molecule active

    2 trials
  17. Oxytocin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Mental Health Wellness 1

    small molecule active

    1 trial
  18. Oxytocin

    United Therapeutics Europe Ltd

    Posttraumatic Stress Disorder

    small molecule completed

    1 trial
  19. Oxytocin

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    small molecule completed

    1 trial
  20. Oxytocin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Social Behavior

    small molecule completed

    1 trial
  21. Oxytocin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Postpartum Hemorrhage

    small molecule completed

    1 trial
  22. intranasal oxytocin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Learning Disabilities

    small molecule active

    1 trial
  23. intranasal oxytocin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Healthy

    small molecule active

    7 trials
  24. oxytocin

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Interoception

    small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.